Antihypertensive drugs and risk of COVID-19?

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 32222168)

Published in Lancet Respir Med on March 26, 2020

Authors

Author Affiliations

1: Center for Drug Evaluation & Safety, Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL 32606, USA. Electronic address: joshua.brown@ufl.edu.

Articles citing this ↘

Antihypertensive drugs and risk of COVID-19? Lancet Respir Med (2020) 0.75

Antihypertensive drugs and risk of COVID-19? - Authors' reply. Lancet Respir Med (2020) 0.75

Articles cited by this ↗

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med (2020) 7.12